Learning Objectives:
- Understand how digital pathology can improve prediction of recurrence in HR+/HER2- breast cancer
- Utilize clinicopathologic characteristics in combination with genomic testing to risk stratify early breast cancer
- Describe how generative artificial intelligence techniques can be leveraged to understand treatment response
Session date:
09/11/2023 - 12:00pm to 1:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Frederick Howard, MD